iShares US Aerospace & Defense ETF vs 10X Genomics Inc — how do they compare? iShares US Aerospace & Defense ETF trades at $206.65 (market cap $11.87B), while 10X Genomics Inc trades at $80.65 (market cap $10.07B). The key difference: iShares US Aerospace & Defense ETF is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, iShares US Aerospace & Defense ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares US Aerospace & Defense ETF for 19 Days and 10X Genomics Inc for 91 Days on average.
| ITA | TXG | |
|---|---|---|
Market Cap | $11.87B | $10.07B |
Volume | 1,060,125 | 5,657,286 |
Sector | Sector/Thematic | Health |
52-Week High | $253.22 | $97.74 |
52-Week Low | $198.23 | $11.48 |
Typical Hold Time | 19 Days | 91 Days |
Enterprise Value | — | $9.59B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
10x Genomics (TXG) trades at $77.28, up 1.55% on the day, with a bearish technical signal from moving averages. The company shows improving fundamentals with revenue of $642.82M in 2025 and a reduced net loss of -$43.54M, while recent news highlights strong demand for its Atera spatial biology platform and a patent victory. Positive earnings beats in recent quarters contrast with a high EV/EBITDA of 249.22, indicating significant growth expectations are priced in.
The outlook is mixed; analyst consensus is neutral with a $74.30 price target slightly below the current price, yet operational cash flow turned strongly positive in 2025. Key risks include persistent net losses, high valuation multiples, and execution on new product launches. The stock's near-term direction hinges on Atera's commercial success and achieving profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.
Read more on ITA →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →